Formulary Watch April 2024
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Medicare Advantage enrollees more likely to leave after new complex diagnosis
2
FDA approves Gilead’s Bixlenvo, smallest single-tablet option for virologically suppressed HIV patients
3
FDA approves brepocitinib for rare skin disease
4
Zepbound linked to lower healthcare costs in older adults with obesity
5